| LI, XINXIANG |
NCT02852915: Laparoscopic Surgery for T4 Tumor of the Colon Cancer |
|
|
| Not yet recruiting | 3 | 1960 | RoW | Laparoscopic surgery, Laparoscopic surgery for T4 colon cancers | LI XIN-XIANG | Colonic Neoplasms | 10/19 | 10/24 | | |
NCT03415763: Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy |
|
|
| Recruiting | 3 | 764 | RoW | Capecitabine, Xeloda, mFOLFOX6 or CAPOX, 5-Fu-leucovorin-oxaliplatin or xeloda-oxaliplatin | LI XIN-XIANG | Rectal Neoplasms | 12/20 | 12/25 | | |
NCT04416854: The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer |
|
|
| Recruiting | 3 | 627 | RoW | resection of primary tumor, XELOX, mFOLFOX6 | Fudan University | Metastatic Colon Cancer, Surgery | 12/23 | 12/25 | | |
| Recruiting | 2/3 | 298 | RoW | injecting Carbon Nanoparticles Suspension, Injecting indocyanine green | LI XIN-XIANG | Number of Lymph Node Retrieved | 06/22 | 06/23 | | |
MRIMR-2, NCT05359406: A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis |
|
|
| Not yet recruiting | 2 | 51 | RoW | a combination therapy including tislelizumab, Radiotherapy Followed by Chemotherapy with target therapy and anti-PD-1 immunotherapy | LI XIN-XIANG | Advanced Rectal Cancer, Distal Metastasis | 06/24 | 12/24 | | |
NCT05969899: Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer |
|
|
| Active, not recruiting | 2 | 50 | RoW | FOLFIRI+Bevacizumab | Fudan University | Colorectal Cancer | 07/25 | 02/27 | | |
NCT06010888: Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC |
|
|
| Recruiting | 2 | 92 | RoW | Fruquintinib+mFOLFOX6/FOLFIRI | Fudan University | Colorectal Cancer | 10/24 | 03/26 | | |
| Recruiting | N/A | 957 | RoW | Laparoscopic surgery, Laparoscopic surgery for T4 colon cancers | LI XIN-XIANG | Colonic Neoplasms | 10/19 | 10/24 | | |
NCT05645094: Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer |
|
|
| Not yet recruiting | N/A | 38 | NA | Envafolimab | Fudan University | Locally Advanced Rectal Carcinoma, MSI-High | 06/23 | 06/26 | | |
NCT06146946: Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H) |
|
|
| Not yet recruiting | N/A | 1384 | RoW | Dissection of the No.253 lymph node, Omitting the dissection of the No.253 lymph node | Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, China-Japan Friendship Hospital, Chinese PLA General Hospital, Ruijin Hospital, Fudan University, West China Hospital, Peking University Cancer Hospital & Institute | Rectal Cancer | 12/26 | 12/29 | | |
NCT06204497: The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients |
|
|
| Recruiting | N/A | 570 | RoW | Stent-based Diverting Technique | Sir Run Run Shaw Hospital | Rectal Neoplasms | 12/24 | 06/25 | | |
NCT05923255: LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer |
|
|
| Recruiting | N/A | 568 | RoW | LISH （Laparoscopic Ileocecal-Sparing Right Hemicolectomy）, TRH（Traditional Laparoscopic Right Hemicolectomy） | Zhejiang University | Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer | 05/26 | 05/31 | | |
NCT03349762: Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery |
|
|
| Recruiting | N/A | 3060 | RoW | | Xi Shan Wang | Colorectal Cancer | 12/27 | 06/28 | | |
